Abstract:Objective To analyze the suspicious results of serum HBV DNA by fluorescence quantitative PCR and develop appropriate countermeasures in order to improve the quality of detection of HBV DNA.Methods Blood samples of patients from the First Affiliated Hospital of Wenzhou Medical College from 2008 to 2011 were analyzed for HBV DNA by fluorescence quantitative PCR.1969 cases of suspicious results,judged by the rule of review the results of serum HBV DNA combined with the historical results,PCR amplification curve,HBV serum markers and clinical diagnosis,were analyzed and redetected by using of two different reagents,careHBV PCR Kit and careHBV PCR Kit V2,at the same time.The consistency and inconsistency ratio of the results were evaluated.Both the reasons of inconsistent and the undetected rates of careHBV PCR Kit were analyzed.The two reasons for the inconsistent results included the reagent related factors,e.g,showing no amplification curve caused by the false negative and abnormal low efficiency of amplification curve,and the non reagent related factors such as operating pollution and other sample factors.Results There were 115 154 blood samples were detected for HBV from 2008 to 2011 and 1969 samples (1.71％) with suspicious results were redetected.The consistency and inconsistency results were 1588 (80.65％) and 381 (19.35％),respectively.Every year from 2008 to 2011,the percentage of the inconsistent results caused by the reagent related factors were 18.87％,20.23％,51.33％ and 59.57％ respectively,which showed an increasing trend,and the percentage of inconsistent results caused by the nonreagent related factors were 81.13％,79.77％,48.67％ and 40.43％ respectively,which showed a declining trend year by year.The undetected rates of careHBV PCR Kit were 2.49％,4.08％,10.09％ and 14.47％ respectively,showing an increasing trend.Conclusions The redetection for the specimens with the suspicious results by using of different reagents can avoid the blind detection of HBV DNA and reduce the experimental error.All the clinical samples for quantitative HBV DNA including the mutations of HBV gene can be measured accurately and effectively,which is helpful to hepatitis B patients for antiviral therapy.

Pilot Study on Hepatitis B Virus Core Promoter Mutations in Patients

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Study on hepatitis B virus genotypes in Wenzhou district by PCR using type-specific primers and its clinical significance

A Study on the Heterogeneity of Core Promoter Region in Hepatitis B Virus DNA

Detecting of the Hepatic Fibrotic Indexes and Serous Markers from Patients with Chronic Hepatitis B (chb)and Variation of HBV DNA YMDD

Quasispecies and Variations of Hepatitis B Virus:Core Promotor Region As an Example

The Measurement of HBV DNA in peripheral blood mononuclear cells and its clinical applicability

Deep sequencing analysis of hepatitis B virus mutations in the basal core promoter and precore regions

[Core Promoter Mutations of HBV Isolated from Patients with Chronic Hepatitis B in Guangxi].

The Prevalence and Significance of HBV Basic Core Promoter/precore Mutations in Untreated Chronic Hepatitis B Patients

Prevalence of Basal Core Promoter and Precore Mutations in Chinese Chronic Hepatitis B Patients and Correlation with Serum HBeAG Titers

Analysis of Hepatitis B Virus Pre-Core Region in Chinese Hepatitis B Patients

Relationship between hepatitis B virus basic core promoter/precore mutations and viral genotypes

The association of primary liver cancer with the mutations in basic core promoter and precore genes of hepatitis B virus

Correlation of Hepatitis B Virus (hbv) Genotypes and Mutations in Basal Core Promoter/Precore with Clinical Features of Chronic Hbv Infection

Relationship Between HBV C Gene Promoter Gene Mutation and Serum HBeAg and HBV DNA Contents

Association Between HBV Precore and Basal Core Promoter Mutations with Progress of Liver Disease in Patients with Chronic HBV Infection

Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

[Prevalence of Hepatitis B Virus Core Promoter Mutant Isolated from Asymptomatic Carriers from Areas with Higher and Lower Incidence of Hepatocellular Carcinoma in Guangxi].